Document qkwwv0gdb0pjr4o5e4yovkQ45
4/26/2024
WP responsible for keeping deadline
WP that need to deliver
Universal PFAS restriction Overall Timeline and Important Milestones
ECHA FFF restriction
Scope Scope defined for RoI (exclusion WP2 and possible E-use WPW7P) 2 and WP7
Scope defined for Annex XV report (ongoing assessments can still lead to changes in scope i.e. substances/substance groups to be excluded, uses to be derogated etc.) 2nd round CfE Call for Evidence for specific information (15. July - 17. October) Assessment of CfE info only for specific information requested (15. September -15. October)
Update of drafts of Annex A and Annex B specifically (15. October- End March)
Annex XV report Part 2 (Annexes) Annex A. Manufacture and uses Annex B. Information on hazard, exposure/emissions and risk
Phys-chem, Grouping Information on hazards
Exposure/Emission Risk
Annex C. Justification for action on a Union-wide basis Annex D. Baseline Annex E. Impact Assessment
Use and function of alternatives Hazards of Alternatives
Monitorability, Practicability Annex F. Assumptions, uncertainties and sensitivities Annex G. Stakeholder information Annex XV Report Part 1 (Summary) 1. Problem identified 1.1. Hazard, exposure/emissions and risk 1.2 Justification for an EU wide restriction measure 1.3. Baseline 2. Impact assessment 2.1. Introduction 2.2. Risk management options 2.3. Response to restriction scenario(s)
WP3, WP4 WP3, WP4, WP7
WP4 sub uses WP2 WP6 WP6, sub-WP4s WP4 WP3, WP4, WP5
WP4 WP4 sub uses WP3, WP4 and WP6
2.4. Economic impacts
2.5. Human health and environmental impacts
2.6. Other impacts
2.7. Practicability and monitorability
2.8. Proportionality to the risk (including comparison of options)
3. Assumptions, uncertainties and sensitivities
WP7
WP4
4. Conclusion
WP0
Finalisation of dossier for submission
Lay-out, text combining, proof-reading, final adjustments WP0
Unexpected delay, dossier submission
WP0
Ministry involvement (commenting periods)
Draft entry text
Draft dossier
Organizational actions
Stitching dossier together
Commenting round all MS if desired/needed with ministry
Further points to consider Endnote to be used as citation tool
Legend WP0: blue WP1: green WP2: orange WP3: yellow WP4: grey WP5: purple WP6: WP7: red/brown
First draft = 70 % ready Final draft = 90 % ready
First draft (70% Final draft version) (90% version)
Final Deadline
Jan 22
Feb 22
Mar 22
Apr 22 May 22
Submission
7/15/2021 10/31/2021
Conformity Check
First RAC/SEAC discussion
Public consultati
9/30/2021 6/30/2022 1/31/2022 11/30/2021 9/30/2021 11/30/2021
4/30/2022 5/31/2022
9/30/2021
9/30/2021 6/30/2022
5/31/2022 8/31/2022 2/28/2022 1/31/2022 11/30/2021 1/31/2022
6/30/2022 7/31/2022
11/30/2021 1/31/2022
4/29/2022 8/31/2022
6/30/2022 9/30/2022 4/15/2022 5/15/2022 6/30/2022 6/30/2022 4/30/2022 8/31/2022 9/30/2022 6/30/2022 4/15/2022 4/30/2022 9/30/2022 4/30/2022
9/30/2022 4/30/2022 8/31/2022
10/31/2022 10/31/2022 10/31/2022
final draft
final draft
final final
final first draft
first draft
final draft
final final
first draft final
final
10/31/2022 10/31/2022 10/31/2022 10/31/2022 10/31/2022 10/31/2022 11/30/2022
12/31/2022 12/13/2022
Jun 22
Jul 22
Aug 22 Sep 22 Oct 22 Nov 22 Dec 22
Jan 23
Public consultation
Second RAC/SEAC discussion
Proof reading, connecting loose ends, etc.
Submission
final
final draft
final
final
final draft final
final draft
final final
first draft
final draft
final
final
final
final final final
final final final final final final
final
CW 22-25
CW26-27 CW28-35
CW36-37
CW46-47
CW44-45 CW49 CW 01-02 CW46-48 CW50-52
Author: Changes in this pe submission only im
by notifying them responsible CA (re
not defined yet).
Feb 23 March 23
Author: Changes in this period up until submission only implementable
by notifying them via mail to the responsible CA (responsible CA is
not defined yet).